Global Vaccine Excipients Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our (LP Info Research) latest study, the global Vaccine Excipients market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Vaccine Excipients is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Vaccine Excipients market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Vaccine Excipients are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccine Excipients. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccine Excipients market.
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
Key Features:
The report on Vaccine Excipients market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccine Excipients market. It may include historical data, market segmentation by Type (e.g., Vaccine Stabilizers, Vaccine Emulsifiers), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccine Excipients market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccine Excipients market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccine Excipients industry. This include advancements in Vaccine Excipients technology, Vaccine Excipients new entrants, Vaccine Excipients new investment, and other innovations that are shaping the future of Vaccine Excipients.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccine Excipients market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccine Excipients product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccine Excipients market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccine Excipients market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccine Excipients market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccine Excipients industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccine Excipients market.
Market Segmentation:
Vaccine Excipients market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Vaccine Excipients market?
What factors are driving Vaccine Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Excipients market opportunities vary by end market size?
How does Vaccine Excipients break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
According to our (LP Info Research) latest study, the global Vaccine Excipients market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Vaccine Excipients is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Vaccine Excipients market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Vaccine Excipients are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccine Excipients. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccine Excipients market.
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
Key Features:
The report on Vaccine Excipients market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccine Excipients market. It may include historical data, market segmentation by Type (e.g., Vaccine Stabilizers, Vaccine Emulsifiers), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccine Excipients market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccine Excipients market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccine Excipients industry. This include advancements in Vaccine Excipients technology, Vaccine Excipients new entrants, Vaccine Excipients new investment, and other innovations that are shaping the future of Vaccine Excipients.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccine Excipients market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccine Excipients product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccine Excipients market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccine Excipients market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccine Excipients market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccine Excipients industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccine Excipients market.
Market Segmentation:
Vaccine Excipients market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Vaccine Stabilizers
- Vaccine Emulsifiers
- Vaccine Adjuvants
- Preservatives
- Research Applications
- Commercial Applications
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Curia
- Croda Pharma
- Alfa Chemistry
- A & C
- Avantor
- GS
- SEPPIC
- Novavax
- Dynavax Technologies
- Sanofi
- Zhifei Biological
- Escon
- Rico Bio
- CSL Limited
- Creative Biolabs
- Central Drug House
What is the 10-year outlook for the global Vaccine Excipients market?
What factors are driving Vaccine Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Excipients market opportunities vary by end market size?
How does Vaccine Excipients break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Excipients Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vaccine Excipients by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vaccine Excipients by Country/Region, 2018, 2022 & 2029
2.2 Vaccine Excipients Segment by Type
2.2.1 Vaccine Stabilizers
2.2.2 Vaccine Emulsifiers
2.2.3 Vaccine Adjuvants
2.2.4 Preservatives
2.3 Vaccine Excipients Sales by Type
2.3.1 Global Vaccine Excipients Sales Market Share by Type (2018-2023)
2.3.2 Global Vaccine Excipients Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vaccine Excipients Sale Price by Type (2018-2023)
2.4 Vaccine Excipients Segment by Application
2.4.1 Research Applications
2.4.2 Commercial Applications
2.5 Vaccine Excipients Sales by Application
2.5.1 Global Vaccine Excipients Sale Market Share by Application (2018-2023)
2.5.2 Global Vaccine Excipients Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vaccine Excipients Sale Price by Application (2018-2023)
3 GLOBAL VACCINE EXCIPIENTS BY COMPANY
3.1 Global Vaccine Excipients Breakdown Data by Company
3.1.1 Global Vaccine Excipients Annual Sales by Company (2018-2023)
3.1.2 Global Vaccine Excipients Sales Market Share by Company (2018-2023)
3.2 Global Vaccine Excipients Annual Revenue by Company (2018-2023)
3.2.1 Global Vaccine Excipients Revenue by Company (2018-2023)
3.2.2 Global Vaccine Excipients Revenue Market Share by Company (2018-2023)
3.3 Global Vaccine Excipients Sale Price by Company
3.4 Key Manufacturers Vaccine Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Excipients Product Location Distribution
3.4.2 Players Vaccine Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Excipients Market Size by Geographic Region (2018-2023)
4.1.1 Global Vaccine Excipients Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vaccine Excipients Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vaccine Excipients Market Size by Country/Region (2018-2023)
4.2.1 Global Vaccine Excipients Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vaccine Excipients Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vaccine Excipients Sales Growth
4.4 APAC Vaccine Excipients Sales Growth
4.5 Europe Vaccine Excipients Sales Growth
4.6 Middle East & Africa Vaccine Excipients Sales Growth
5 AMERICAS
5.1 Americas Vaccine Excipients Sales by Country
5.1.1 Americas Vaccine Excipients Sales by Country (2018-2023)
5.1.2 Americas Vaccine Excipients Revenue by Country (2018-2023)
5.2 Americas Vaccine Excipients Sales by Type
5.3 Americas Vaccine Excipients Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Excipients Sales by Region
6.1.1 APAC Vaccine Excipients Sales by Region (2018-2023)
6.1.2 APAC Vaccine Excipients Revenue by Region (2018-2023)
6.2 APAC Vaccine Excipients Sales by Type
6.3 APAC Vaccine Excipients Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Excipients by Country
7.1.1 Europe Vaccine Excipients Sales by Country (2018-2023)
7.1.2 Europe Vaccine Excipients Revenue by Country (2018-2023)
7.2 Europe Vaccine Excipients Sales by Type
7.3 Europe Vaccine Excipients Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Excipients by Country
8.1.1 Middle East & Africa Vaccine Excipients Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vaccine Excipients Revenue by Country (2018-2023)
8.2 Middle East & Africa Vaccine Excipients Sales by Type
8.3 Middle East & Africa Vaccine Excipients Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Excipients
10.3 Manufacturing Process Analysis of Vaccine Excipients
10.4 Industry Chain Structure of Vaccine Excipients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Excipients Distributors
11.3 Vaccine Excipients Customer
12 WORLD FORECAST REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
12.1 Global Vaccine Excipients Market Size Forecast by Region
12.1.1 Global Vaccine Excipients Forecast by Region (2024-2029)
12.1.2 Global Vaccine Excipients Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccine Excipients Forecast by Type
12.7 Global Vaccine Excipients Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Curia
13.1.1 Curia Company Information
13.1.2 Curia Vaccine Excipients Product Portfolios and Specifications
13.1.3 Curia Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Curia Main Business Overview
13.1.5 Curia Latest Developments
13.2 Croda Pharma
13.2.1 Croda Pharma Company Information
13.2.2 Croda Pharma Vaccine Excipients Product Portfolios and Specifications
13.2.3 Croda Pharma Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Croda Pharma Main Business Overview
13.2.5 Croda Pharma Latest Developments
13.3 Alfa Chemistry
13.3.1 Alfa Chemistry Company Information
13.3.2 Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
13.3.3 Alfa Chemistry Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Alfa Chemistry Main Business Overview
13.3.5 Alfa Chemistry Latest Developments
13.4 A & C
13.4.1 A & C Company Information
13.4.2 A & C Vaccine Excipients Product Portfolios and Specifications
13.4.3 A & C Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 A & C Main Business Overview
13.4.5 A & C Latest Developments
13.5 Avantor
13.5.1 Avantor Company Information
13.5.2 Avantor Vaccine Excipients Product Portfolios and Specifications
13.5.3 Avantor Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Avantor Main Business Overview
13.5.5 Avantor Latest Developments
13.6 GS
13.6.1 GS Company Information
13.6.2 GS Vaccine Excipients Product Portfolios and Specifications
13.6.3 GS Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GS Main Business Overview
13.6.5 GS Latest Developments
13.7 SEPPIC
13.7.1 SEPPIC Company Information
13.7.2 SEPPIC Vaccine Excipients Product Portfolios and Specifications
13.7.3 SEPPIC Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 SEPPIC Main Business Overview
13.7.5 SEPPIC Latest Developments
13.8 Novavax
13.8.1 Novavax Company Information
13.8.2 Novavax Vaccine Excipients Product Portfolios and Specifications
13.8.3 Novavax Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novavax Main Business Overview
13.8.5 Novavax Latest Developments
13.9 Dynavax Technologies
13.9.1 Dynavax Technologies Company Information
13.9.2 Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
13.9.3 Dynavax Technologies Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Dynavax Technologies Main Business Overview
13.9.5 Dynavax Technologies Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Vaccine Excipients Product Portfolios and Specifications
13.10.3 Sanofi Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Zhifei Biological
13.11.1 Zhifei Biological Company Information
13.11.2 Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
13.11.3 Zhifei Biological Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhifei Biological Main Business Overview
13.11.5 Zhifei Biological Latest Developments
13.12 Escon
13.12.1 Escon Company Information
13.12.2 Escon Vaccine Excipients Product Portfolios and Specifications
13.12.3 Escon Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Escon Main Business Overview
13.12.5 Escon Latest Developments
13.13 Rico Bio
13.13.1 Rico Bio Company Information
13.13.2 Rico Bio Vaccine Excipients Product Portfolios and Specifications
13.13.3 Rico Bio Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Rico Bio Main Business Overview
13.13.5 Rico Bio Latest Developments
13.14 CSL Limited
13.14.1 CSL Limited Company Information
13.14.2 CSL Limited Vaccine Excipients Product Portfolios and Specifications
13.14.3 CSL Limited Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 CSL Limited Main Business Overview
13.14.5 CSL Limited Latest Developments
13.15 Creative Biolabs
13.15.1 Creative Biolabs Company Information
13.15.2 Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
13.15.3 Creative Biolabs Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Creative Biolabs Main Business Overview
13.15.5 Creative Biolabs Latest Developments
13.16 Central Drug House
13.16.1 Central Drug House Company Information
13.16.2 Central Drug House Vaccine Excipients Product Portfolios and Specifications
13.16.3 Central Drug House Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Central Drug House Main Business Overview
13.16.5 Central Drug House Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Excipients Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vaccine Excipients by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vaccine Excipients by Country/Region, 2018, 2022 & 2029
2.2 Vaccine Excipients Segment by Type
2.2.1 Vaccine Stabilizers
2.2.2 Vaccine Emulsifiers
2.2.3 Vaccine Adjuvants
2.2.4 Preservatives
2.3 Vaccine Excipients Sales by Type
2.3.1 Global Vaccine Excipients Sales Market Share by Type (2018-2023)
2.3.2 Global Vaccine Excipients Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vaccine Excipients Sale Price by Type (2018-2023)
2.4 Vaccine Excipients Segment by Application
2.4.1 Research Applications
2.4.2 Commercial Applications
2.5 Vaccine Excipients Sales by Application
2.5.1 Global Vaccine Excipients Sale Market Share by Application (2018-2023)
2.5.2 Global Vaccine Excipients Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vaccine Excipients Sale Price by Application (2018-2023)
3 GLOBAL VACCINE EXCIPIENTS BY COMPANY
3.1 Global Vaccine Excipients Breakdown Data by Company
3.1.1 Global Vaccine Excipients Annual Sales by Company (2018-2023)
3.1.2 Global Vaccine Excipients Sales Market Share by Company (2018-2023)
3.2 Global Vaccine Excipients Annual Revenue by Company (2018-2023)
3.2.1 Global Vaccine Excipients Revenue by Company (2018-2023)
3.2.2 Global Vaccine Excipients Revenue Market Share by Company (2018-2023)
3.3 Global Vaccine Excipients Sale Price by Company
3.4 Key Manufacturers Vaccine Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Excipients Product Location Distribution
3.4.2 Players Vaccine Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Excipients Market Size by Geographic Region (2018-2023)
4.1.1 Global Vaccine Excipients Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vaccine Excipients Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vaccine Excipients Market Size by Country/Region (2018-2023)
4.2.1 Global Vaccine Excipients Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vaccine Excipients Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vaccine Excipients Sales Growth
4.4 APAC Vaccine Excipients Sales Growth
4.5 Europe Vaccine Excipients Sales Growth
4.6 Middle East & Africa Vaccine Excipients Sales Growth
5 AMERICAS
5.1 Americas Vaccine Excipients Sales by Country
5.1.1 Americas Vaccine Excipients Sales by Country (2018-2023)
5.1.2 Americas Vaccine Excipients Revenue by Country (2018-2023)
5.2 Americas Vaccine Excipients Sales by Type
5.3 Americas Vaccine Excipients Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Excipients Sales by Region
6.1.1 APAC Vaccine Excipients Sales by Region (2018-2023)
6.1.2 APAC Vaccine Excipients Revenue by Region (2018-2023)
6.2 APAC Vaccine Excipients Sales by Type
6.3 APAC Vaccine Excipients Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Excipients by Country
7.1.1 Europe Vaccine Excipients Sales by Country (2018-2023)
7.1.2 Europe Vaccine Excipients Revenue by Country (2018-2023)
7.2 Europe Vaccine Excipients Sales by Type
7.3 Europe Vaccine Excipients Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Excipients by Country
8.1.1 Middle East & Africa Vaccine Excipients Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vaccine Excipients Revenue by Country (2018-2023)
8.2 Middle East & Africa Vaccine Excipients Sales by Type
8.3 Middle East & Africa Vaccine Excipients Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Excipients
10.3 Manufacturing Process Analysis of Vaccine Excipients
10.4 Industry Chain Structure of Vaccine Excipients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Excipients Distributors
11.3 Vaccine Excipients Customer
12 WORLD FORECAST REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
12.1 Global Vaccine Excipients Market Size Forecast by Region
12.1.1 Global Vaccine Excipients Forecast by Region (2024-2029)
12.1.2 Global Vaccine Excipients Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccine Excipients Forecast by Type
12.7 Global Vaccine Excipients Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Curia
13.1.1 Curia Company Information
13.1.2 Curia Vaccine Excipients Product Portfolios and Specifications
13.1.3 Curia Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Curia Main Business Overview
13.1.5 Curia Latest Developments
13.2 Croda Pharma
13.2.1 Croda Pharma Company Information
13.2.2 Croda Pharma Vaccine Excipients Product Portfolios and Specifications
13.2.3 Croda Pharma Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Croda Pharma Main Business Overview
13.2.5 Croda Pharma Latest Developments
13.3 Alfa Chemistry
13.3.1 Alfa Chemistry Company Information
13.3.2 Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
13.3.3 Alfa Chemistry Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Alfa Chemistry Main Business Overview
13.3.5 Alfa Chemistry Latest Developments
13.4 A & C
13.4.1 A & C Company Information
13.4.2 A & C Vaccine Excipients Product Portfolios and Specifications
13.4.3 A & C Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 A & C Main Business Overview
13.4.5 A & C Latest Developments
13.5 Avantor
13.5.1 Avantor Company Information
13.5.2 Avantor Vaccine Excipients Product Portfolios and Specifications
13.5.3 Avantor Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Avantor Main Business Overview
13.5.5 Avantor Latest Developments
13.6 GS
13.6.1 GS Company Information
13.6.2 GS Vaccine Excipients Product Portfolios and Specifications
13.6.3 GS Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GS Main Business Overview
13.6.5 GS Latest Developments
13.7 SEPPIC
13.7.1 SEPPIC Company Information
13.7.2 SEPPIC Vaccine Excipients Product Portfolios and Specifications
13.7.3 SEPPIC Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 SEPPIC Main Business Overview
13.7.5 SEPPIC Latest Developments
13.8 Novavax
13.8.1 Novavax Company Information
13.8.2 Novavax Vaccine Excipients Product Portfolios and Specifications
13.8.3 Novavax Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novavax Main Business Overview
13.8.5 Novavax Latest Developments
13.9 Dynavax Technologies
13.9.1 Dynavax Technologies Company Information
13.9.2 Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
13.9.3 Dynavax Technologies Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Dynavax Technologies Main Business Overview
13.9.5 Dynavax Technologies Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Vaccine Excipients Product Portfolios and Specifications
13.10.3 Sanofi Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Zhifei Biological
13.11.1 Zhifei Biological Company Information
13.11.2 Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
13.11.3 Zhifei Biological Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhifei Biological Main Business Overview
13.11.5 Zhifei Biological Latest Developments
13.12 Escon
13.12.1 Escon Company Information
13.12.2 Escon Vaccine Excipients Product Portfolios and Specifications
13.12.3 Escon Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Escon Main Business Overview
13.12.5 Escon Latest Developments
13.13 Rico Bio
13.13.1 Rico Bio Company Information
13.13.2 Rico Bio Vaccine Excipients Product Portfolios and Specifications
13.13.3 Rico Bio Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Rico Bio Main Business Overview
13.13.5 Rico Bio Latest Developments
13.14 CSL Limited
13.14.1 CSL Limited Company Information
13.14.2 CSL Limited Vaccine Excipients Product Portfolios and Specifications
13.14.3 CSL Limited Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 CSL Limited Main Business Overview
13.14.5 CSL Limited Latest Developments
13.15 Creative Biolabs
13.15.1 Creative Biolabs Company Information
13.15.2 Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
13.15.3 Creative Biolabs Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Creative Biolabs Main Business Overview
13.15.5 Creative Biolabs Latest Developments
13.16 Central Drug House
13.16.1 Central Drug House Company Information
13.16.2 Central Drug House Vaccine Excipients Product Portfolios and Specifications
13.16.3 Central Drug House Vaccine Excipients Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Central Drug House Main Business Overview
13.16.5 Central Drug House Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine Excipients Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vaccine Excipients Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vaccine Stabilizers
Table 4. Major Players of Vaccine Emulsifiers
Table 5. Major Players of Vaccine Adjuvants
Table 6. Major Players of Preservatives
Table 7. Global Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 8. Global Vaccine Excipients Sales Market Share by Type (2018-2023)
Table 9. Global Vaccine Excipients Revenue by Type (2018-2023) & ($ million)
Table 10. Global Vaccine Excipients Revenue Market Share by Type (2018-2023)
Table 11. Global Vaccine Excipients Sale Price by Type (2018-2023) & (US$/g)
Table 12. Global Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 13. Global Vaccine Excipients Sales Market Share by Application (2018-2023)
Table 14. Global Vaccine Excipients Revenue by Application (2018-2023)
Table 15. Global Vaccine Excipients Revenue Market Share by Application (2018-2023)
Table 16. Global Vaccine Excipients Sale Price by Application (2018-2023) & (US$/g)
Table 17. Global Vaccine Excipients Sales by Company (2018-2023) & (kg)
Table 18. Global Vaccine Excipients Sales Market Share by Company (2018-2023)
Table 19. Global Vaccine Excipients Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Vaccine Excipients Revenue Market Share by Company (2018-2023)
Table 21. Global Vaccine Excipients Sale Price by Company (2018-2023) & (US$/g)
Table 22. Key Manufacturers Vaccine Excipients Producing Area Distribution and Sales Area
Table 23. Players Vaccine Excipients Products Offered
Table 24. Vaccine Excipients Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccine Excipients Sales by Geographic Region (2018-2023) & (kg)
Table 28. Global Vaccine Excipients Sales Market Share Geographic Region (2018-2023)
Table 29. Global Vaccine Excipients Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Vaccine Excipients Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Vaccine Excipients Sales by Country/Region (2018-2023) & (kg)
Table 32. Global Vaccine Excipients Sales Market Share by Country/Region (2018-2023)
Table 33. Global Vaccine Excipients Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Vaccine Excipients Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Vaccine Excipients Sales by Country (2018-2023) & (kg)
Table 36. Americas Vaccine Excipients Sales Market Share by Country (2018-2023)
Table 37. Americas Vaccine Excipients Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Vaccine Excipients Revenue Market Share by Country (2018-2023)
Table 39. Americas Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 40. Americas Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 41. APAC Vaccine Excipients Sales by Region (2018-2023) & (kg)
Table 42. APAC Vaccine Excipients Sales Market Share by Region (2018-2023)
Table 43. APAC Vaccine Excipients Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Vaccine Excipients Revenue Market Share by Region (2018-2023)
Table 45. APAC Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 46. APAC Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 47. Europe Vaccine Excipients Sales by Country (2018-2023) & (kg)
Table 48. Europe Vaccine Excipients Sales Market Share by Country (2018-2023)
Table 49. Europe Vaccine Excipients Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Vaccine Excipients Revenue Market Share by Country (2018-2023)
Table 51. Europe Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 52. Europe Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 53. Middle East & Africa Vaccine Excipients Sales by Country (2018-2023) & (kg)
Table 54. Middle East & Africa Vaccine Excipients Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vaccine Excipients Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Vaccine Excipients Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 58. Middle East & Africa Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 59. Key Market Drivers & Growth Opportunities of Vaccine Excipients
Table 60. Key Market Challenges & Risks of Vaccine Excipients
Table 61. Key Industry Trends of Vaccine Excipients
Table 62. Vaccine Excipients Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccine Excipients Distributors List
Table 65. Vaccine Excipients Customer List
Table 66. Global Vaccine Excipients Sales Forecast by Region (2024-2029) & (kg)
Table 67. Global Vaccine Excipients Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Vaccine Excipients Sales Forecast by Country (2024-2029) & (kg)
Table 69. Americas Vaccine Excipients Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Vaccine Excipients Sales Forecast by Region (2024-2029) & (kg)
Table 71. APAC Vaccine Excipients Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Vaccine Excipients Sales Forecast by Country (2024-2029) & (kg)
Table 73. Europe Vaccine Excipients Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Vaccine Excipients Sales Forecast by Country (2024-2029) & (kg)
Table 75. Middle East & Africa Vaccine Excipients Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Vaccine Excipients Sales Forecast by Type (2024-2029) & (kg)
Table 77. Global Vaccine Excipients Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Vaccine Excipients Sales Forecast by Application (2024-2029) & (kg)
Table 79. Global Vaccine Excipients Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Curia Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 81. Curia Vaccine Excipients Product Portfolios and Specifications
Table 82. Curia Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 83. Curia Main Business
Table 84. Curia Latest Developments
Table 85. Croda Pharma Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 86. Croda Pharma Vaccine Excipients Product Portfolios and Specifications
Table 87. Croda Pharma Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 88. Croda Pharma Main Business
Table 89. Croda Pharma Latest Developments
Table 90. Alfa Chemistry Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 91. Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
Table 92. Alfa Chemistry Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 93. Alfa Chemistry Main Business
Table 94. Alfa Chemistry Latest Developments
Table 95. A & C Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 96. A & C Vaccine Excipients Product Portfolios and Specifications
Table 97. A & C Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 98. A & C Main Business
Table 99. A & C Latest Developments
Table 100. Avantor Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 101. Avantor Vaccine Excipients Product Portfolios and Specifications
Table 102. Avantor Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 103. Avantor Main Business
Table 104. Avantor Latest Developments
Table 105. GS Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 106. GS Vaccine Excipients Product Portfolios and Specifications
Table 107. GS Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 108. GS Main Business
Table 109. GS Latest Developments
Table 110. SEPPIC Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 111. SEPPIC Vaccine Excipients Product Portfolios and Specifications
Table 112. SEPPIC Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 113. SEPPIC Main Business
Table 114. SEPPIC Latest Developments
Table 115. Novavax Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 116. Novavax Vaccine Excipients Product Portfolios and Specifications
Table 117. Novavax Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 118. Novavax Main Business
Table 119. Novavax Latest Developments
Table 120. Dynavax Technologies Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 121. Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
Table 122. Dynavax Technologies Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 123. Dynavax Technologies Main Business
Table 124. Dynavax Technologies Latest Developments
Table 125. Sanofi Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 126. Sanofi Vaccine Excipients Product Portfolios and Specifications
Table 127. Sanofi Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 128. Sanofi Main Business
Table 129. Sanofi Latest Developments
Table 130. Zhifei Biological Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 131. Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
Table 132. Zhifei Biological Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 133. Zhifei Biological Main Business
Table 134. Zhifei Biological Latest Developments
Table 135. Escon Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 136. Escon Vaccine Excipients Product Portfolios and Specifications
Table 137. Escon Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 138. Escon Main Business
Table 139. Escon Latest Developments
Table 140. Rico Bio Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 141. Rico Bio Vaccine Excipients Product Portfolios and Specifications
Table 142. Rico Bio Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 143. Rico Bio Main Business
Table 144. Rico Bio Latest Developments
Table 145. CSL Limited Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 146. CSL Limited Vaccine Excipients Product Portfolios and Specifications
Table 147. CSL Limited Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 148. CSL Limited Main Business
Table 149. CSL Limited Latest Developments
Table 150. Creative Biolabs Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 151. Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
Table 152. Creative Biolabs Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 153. Creative Biolabs Main Business
Table 154. Creative Biolabs Latest Developments
Table 155. Central Drug House Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 156. Central Drug House Vaccine Excipients Product Portfolios and Specifications
Table 157. Central Drug House Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 158. Central Drug House Main Business
Table 159. Central Drug House Latest Developments
Table 1. Vaccine Excipients Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vaccine Excipients Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vaccine Stabilizers
Table 4. Major Players of Vaccine Emulsifiers
Table 5. Major Players of Vaccine Adjuvants
Table 6. Major Players of Preservatives
Table 7. Global Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 8. Global Vaccine Excipients Sales Market Share by Type (2018-2023)
Table 9. Global Vaccine Excipients Revenue by Type (2018-2023) & ($ million)
Table 10. Global Vaccine Excipients Revenue Market Share by Type (2018-2023)
Table 11. Global Vaccine Excipients Sale Price by Type (2018-2023) & (US$/g)
Table 12. Global Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 13. Global Vaccine Excipients Sales Market Share by Application (2018-2023)
Table 14. Global Vaccine Excipients Revenue by Application (2018-2023)
Table 15. Global Vaccine Excipients Revenue Market Share by Application (2018-2023)
Table 16. Global Vaccine Excipients Sale Price by Application (2018-2023) & (US$/g)
Table 17. Global Vaccine Excipients Sales by Company (2018-2023) & (kg)
Table 18. Global Vaccine Excipients Sales Market Share by Company (2018-2023)
Table 19. Global Vaccine Excipients Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Vaccine Excipients Revenue Market Share by Company (2018-2023)
Table 21. Global Vaccine Excipients Sale Price by Company (2018-2023) & (US$/g)
Table 22. Key Manufacturers Vaccine Excipients Producing Area Distribution and Sales Area
Table 23. Players Vaccine Excipients Products Offered
Table 24. Vaccine Excipients Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccine Excipients Sales by Geographic Region (2018-2023) & (kg)
Table 28. Global Vaccine Excipients Sales Market Share Geographic Region (2018-2023)
Table 29. Global Vaccine Excipients Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Vaccine Excipients Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Vaccine Excipients Sales by Country/Region (2018-2023) & (kg)
Table 32. Global Vaccine Excipients Sales Market Share by Country/Region (2018-2023)
Table 33. Global Vaccine Excipients Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Vaccine Excipients Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Vaccine Excipients Sales by Country (2018-2023) & (kg)
Table 36. Americas Vaccine Excipients Sales Market Share by Country (2018-2023)
Table 37. Americas Vaccine Excipients Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Vaccine Excipients Revenue Market Share by Country (2018-2023)
Table 39. Americas Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 40. Americas Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 41. APAC Vaccine Excipients Sales by Region (2018-2023) & (kg)
Table 42. APAC Vaccine Excipients Sales Market Share by Region (2018-2023)
Table 43. APAC Vaccine Excipients Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Vaccine Excipients Revenue Market Share by Region (2018-2023)
Table 45. APAC Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 46. APAC Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 47. Europe Vaccine Excipients Sales by Country (2018-2023) & (kg)
Table 48. Europe Vaccine Excipients Sales Market Share by Country (2018-2023)
Table 49. Europe Vaccine Excipients Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Vaccine Excipients Revenue Market Share by Country (2018-2023)
Table 51. Europe Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 52. Europe Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 53. Middle East & Africa Vaccine Excipients Sales by Country (2018-2023) & (kg)
Table 54. Middle East & Africa Vaccine Excipients Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vaccine Excipients Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Vaccine Excipients Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Vaccine Excipients Sales by Type (2018-2023) & (kg)
Table 58. Middle East & Africa Vaccine Excipients Sales by Application (2018-2023) & (kg)
Table 59. Key Market Drivers & Growth Opportunities of Vaccine Excipients
Table 60. Key Market Challenges & Risks of Vaccine Excipients
Table 61. Key Industry Trends of Vaccine Excipients
Table 62. Vaccine Excipients Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccine Excipients Distributors List
Table 65. Vaccine Excipients Customer List
Table 66. Global Vaccine Excipients Sales Forecast by Region (2024-2029) & (kg)
Table 67. Global Vaccine Excipients Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Vaccine Excipients Sales Forecast by Country (2024-2029) & (kg)
Table 69. Americas Vaccine Excipients Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Vaccine Excipients Sales Forecast by Region (2024-2029) & (kg)
Table 71. APAC Vaccine Excipients Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Vaccine Excipients Sales Forecast by Country (2024-2029) & (kg)
Table 73. Europe Vaccine Excipients Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Vaccine Excipients Sales Forecast by Country (2024-2029) & (kg)
Table 75. Middle East & Africa Vaccine Excipients Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Vaccine Excipients Sales Forecast by Type (2024-2029) & (kg)
Table 77. Global Vaccine Excipients Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Vaccine Excipients Sales Forecast by Application (2024-2029) & (kg)
Table 79. Global Vaccine Excipients Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Curia Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 81. Curia Vaccine Excipients Product Portfolios and Specifications
Table 82. Curia Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 83. Curia Main Business
Table 84. Curia Latest Developments
Table 85. Croda Pharma Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 86. Croda Pharma Vaccine Excipients Product Portfolios and Specifications
Table 87. Croda Pharma Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 88. Croda Pharma Main Business
Table 89. Croda Pharma Latest Developments
Table 90. Alfa Chemistry Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 91. Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
Table 92. Alfa Chemistry Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 93. Alfa Chemistry Main Business
Table 94. Alfa Chemistry Latest Developments
Table 95. A & C Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 96. A & C Vaccine Excipients Product Portfolios and Specifications
Table 97. A & C Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 98. A & C Main Business
Table 99. A & C Latest Developments
Table 100. Avantor Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 101. Avantor Vaccine Excipients Product Portfolios and Specifications
Table 102. Avantor Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 103. Avantor Main Business
Table 104. Avantor Latest Developments
Table 105. GS Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 106. GS Vaccine Excipients Product Portfolios and Specifications
Table 107. GS Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 108. GS Main Business
Table 109. GS Latest Developments
Table 110. SEPPIC Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 111. SEPPIC Vaccine Excipients Product Portfolios and Specifications
Table 112. SEPPIC Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 113. SEPPIC Main Business
Table 114. SEPPIC Latest Developments
Table 115. Novavax Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 116. Novavax Vaccine Excipients Product Portfolios and Specifications
Table 117. Novavax Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 118. Novavax Main Business
Table 119. Novavax Latest Developments
Table 120. Dynavax Technologies Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 121. Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
Table 122. Dynavax Technologies Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 123. Dynavax Technologies Main Business
Table 124. Dynavax Technologies Latest Developments
Table 125. Sanofi Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 126. Sanofi Vaccine Excipients Product Portfolios and Specifications
Table 127. Sanofi Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 128. Sanofi Main Business
Table 129. Sanofi Latest Developments
Table 130. Zhifei Biological Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 131. Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
Table 132. Zhifei Biological Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 133. Zhifei Biological Main Business
Table 134. Zhifei Biological Latest Developments
Table 135. Escon Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 136. Escon Vaccine Excipients Product Portfolios and Specifications
Table 137. Escon Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 138. Escon Main Business
Table 139. Escon Latest Developments
Table 140. Rico Bio Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 141. Rico Bio Vaccine Excipients Product Portfolios and Specifications
Table 142. Rico Bio Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 143. Rico Bio Main Business
Table 144. Rico Bio Latest Developments
Table 145. CSL Limited Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 146. CSL Limited Vaccine Excipients Product Portfolios and Specifications
Table 147. CSL Limited Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 148. CSL Limited Main Business
Table 149. CSL Limited Latest Developments
Table 150. Creative Biolabs Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 151. Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
Table 152. Creative Biolabs Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 153. Creative Biolabs Main Business
Table 154. Creative Biolabs Latest Developments
Table 155. Central Drug House Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 156. Central Drug House Vaccine Excipients Product Portfolios and Specifications
Table 157. Central Drug House Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 158. Central Drug House Main Business
Table 159. Central Drug House Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccine Excipients
Figure 2. Vaccine Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Excipients Sales Growth Rate 2018-2029 (kg)
Figure 7. Global Vaccine Excipients Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vaccine Excipients Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vaccine Stabilizers
Figure 10. Product Picture of Vaccine Emulsifiers
Figure 11. Product Picture of Vaccine Adjuvants
Figure 12. Product Picture of Preservatives
Figure 13. Global Vaccine Excipients Sales Market Share by Type in 2022
Figure 14. Global Vaccine Excipients Revenue Market Share by Type (2018-2023)
Figure 15. Vaccine Excipients Consumed in Research Applications
Figure 16. Global Vaccine Excipients Market: Research Applications (2018-2023) & (kg)
Figure 17. Vaccine Excipients Consumed in Commercial Applications
Figure 18. Global Vaccine Excipients Market: Commercial Applications (2018-2023) & (kg)
Figure 19. Global Vaccine Excipients Sales Market Share by Application (2022)
Figure 20. Global Vaccine Excipients Revenue Market Share by Application in 2022
Figure 21. Vaccine Excipients Sales Market by Company in 2022 (kg)
Figure 22. Global Vaccine Excipients Sales Market Share by Company in 2022
Figure 23. Vaccine Excipients Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Vaccine Excipients Revenue Market Share by Company in 2022
Figure 25. Global Vaccine Excipients Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Vaccine Excipients Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Vaccine Excipients Sales 2018-2023 (kg)
Figure 28. Americas Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 29. APAC Vaccine Excipients Sales 2018-2023 (kg)
Figure 30. APAC Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 31. Europe Vaccine Excipients Sales 2018-2023 (kg)
Figure 32. Europe Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Vaccine Excipients Sales 2018-2023 (kg)
Figure 34. Middle East & Africa Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 35. Americas Vaccine Excipients Sales Market Share by Country in 2022
Figure 36. Americas Vaccine Excipients Revenue Market Share by Country in 2022
Figure 37. Americas Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 38. Americas Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 39. United States Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Vaccine Excipients Sales Market Share by Region in 2022
Figure 44. APAC Vaccine Excipients Revenue Market Share by Regions in 2022
Figure 45. APAC Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 46. APAC Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 47. China Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Vaccine Excipients Sales Market Share by Country in 2022
Figure 55. Europe Vaccine Excipients Revenue Market Share by Country in 2022
Figure 56. Europe Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 57. Europe Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 58. Germany Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Vaccine Excipients Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Vaccine Excipients Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 67. Egypt Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Vaccine Excipients in 2022
Figure 73. Manufacturing Process Analysis of Vaccine Excipients
Figure 74. Industry Chain Structure of Vaccine Excipients
Figure 75. Channels of Distribution
Figure 76. Global Vaccine Excipients Sales Market Forecast by Region (2024-2029)
Figure 77. Global Vaccine Excipients Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Vaccine Excipients Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Vaccine Excipients Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Vaccine Excipients Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Vaccine Excipients Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Vaccine Excipients
Figure 2. Vaccine Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Excipients Sales Growth Rate 2018-2029 (kg)
Figure 7. Global Vaccine Excipients Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vaccine Excipients Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vaccine Stabilizers
Figure 10. Product Picture of Vaccine Emulsifiers
Figure 11. Product Picture of Vaccine Adjuvants
Figure 12. Product Picture of Preservatives
Figure 13. Global Vaccine Excipients Sales Market Share by Type in 2022
Figure 14. Global Vaccine Excipients Revenue Market Share by Type (2018-2023)
Figure 15. Vaccine Excipients Consumed in Research Applications
Figure 16. Global Vaccine Excipients Market: Research Applications (2018-2023) & (kg)
Figure 17. Vaccine Excipients Consumed in Commercial Applications
Figure 18. Global Vaccine Excipients Market: Commercial Applications (2018-2023) & (kg)
Figure 19. Global Vaccine Excipients Sales Market Share by Application (2022)
Figure 20. Global Vaccine Excipients Revenue Market Share by Application in 2022
Figure 21. Vaccine Excipients Sales Market by Company in 2022 (kg)
Figure 22. Global Vaccine Excipients Sales Market Share by Company in 2022
Figure 23. Vaccine Excipients Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Vaccine Excipients Revenue Market Share by Company in 2022
Figure 25. Global Vaccine Excipients Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Vaccine Excipients Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Vaccine Excipients Sales 2018-2023 (kg)
Figure 28. Americas Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 29. APAC Vaccine Excipients Sales 2018-2023 (kg)
Figure 30. APAC Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 31. Europe Vaccine Excipients Sales 2018-2023 (kg)
Figure 32. Europe Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Vaccine Excipients Sales 2018-2023 (kg)
Figure 34. Middle East & Africa Vaccine Excipients Revenue 2018-2023 ($ Millions)
Figure 35. Americas Vaccine Excipients Sales Market Share by Country in 2022
Figure 36. Americas Vaccine Excipients Revenue Market Share by Country in 2022
Figure 37. Americas Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 38. Americas Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 39. United States Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Vaccine Excipients Sales Market Share by Region in 2022
Figure 44. APAC Vaccine Excipients Revenue Market Share by Regions in 2022
Figure 45. APAC Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 46. APAC Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 47. China Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Vaccine Excipients Sales Market Share by Country in 2022
Figure 55. Europe Vaccine Excipients Revenue Market Share by Country in 2022
Figure 56. Europe Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 57. Europe Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 58. Germany Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Vaccine Excipients Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Vaccine Excipients Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Vaccine Excipients Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Vaccine Excipients Sales Market Share by Application (2018-2023)
Figure 67. Egypt Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Vaccine Excipients Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Vaccine Excipients in 2022
Figure 73. Manufacturing Process Analysis of Vaccine Excipients
Figure 74. Industry Chain Structure of Vaccine Excipients
Figure 75. Channels of Distribution
Figure 76. Global Vaccine Excipients Sales Market Forecast by Region (2024-2029)
Figure 77. Global Vaccine Excipients Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Vaccine Excipients Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Vaccine Excipients Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Vaccine Excipients Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Vaccine Excipients Revenue Market Share Forecast by Application (2024-2029)
